Alaunos Therapeutics Inc (TCRT)

Currency in USD
2.470
-0.130(-5.00%)
Closed·
TCRT Scorecard
Full Analysis
Analysts anticipate sales decline in the current year
Unusual trading volume
TCRT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4302.790
52 wk Range
1.3146.200
Key Statistics
Prev. Close
2.6
Open
2.61
Day's Range
2.43-2.79
52 wk Range
1.314-6.2
Volume
88.02K
Average Volume (3m)
42.13K
1-Year Change
2.77%
Book Value / Share
0.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TCRT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Alaunos Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Alaunos Therapeutics Inc Company Profile

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

Compare TCRT to Peers and Sector

Metrics to compare
TCRT
Peers
Sector
Relationship
P/E Ratio
−1.2x−3.6x−0.5x
PEG Ratio
−0.02−0.020.00
Price/Book
4.6x0.9x2.6x
Price / LTM Sales
446.0x51.7x3.3x
Upside (Analyst Target)
-398.2%43.4%
Fair Value Upside
Unlock8.1%7.1%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.67 / --
Revenue / Forecast
2.00K / --
EPS Revisions
Last 90 days

TCRT Income Statement

People Also Watch

39.345
SMR
-11.94%
2.070
UAVS
-7.59%
15.46
OSCR
+1.98%
5.300
ATYR
+1.15%
1.48
WOLF
-1.99%

FAQ

What Stock Exchange Does Alaunos Therapeutics Trade On?

Alaunos Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Alaunos Therapeutics?

The stock symbol for Alaunos Therapeutics is "TCRT."

What Is the Alaunos Therapeutics Market Cap?

As of today, Alaunos Therapeutics market cap is 4.90M.

What Is Alaunos Therapeutics's Earnings Per Share (TTM)?

The Alaunos Therapeutics EPS (TTM) is -2.54.

From a Technical Analysis Perspective, Is TCRT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alaunos Therapeutics Stock Split?

Alaunos Therapeutics has split 2 times.

How Many Employees Does Alaunos Therapeutics Have?

Alaunos Therapeutics has 1 employees.

What is the current trading status of Alaunos Therapeutics (TCRT)?

As of 08 Aug 2025, Alaunos Therapeutics (TCRT) is trading at a price of 2.47, with a previous close of 2.60. The stock has fluctuated within a day range of 2.43 to 2.79, while its 52-week range spans from 1.31 to 6.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.